Oral angiotensin-(1–7) formulation attenuates structural alterations in established emphysema and protects against subsequent allergic airway inflammation

Life Sciences · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles